Ablation of the Regulatory IE1 Protein of Murine Cytomegalovirus Alters In Vivo Pro-inflammatory TNF-alpha Production during Acute Infection by Rodríguez-Martín, Sara et al.
Ablation of the Regulatory IE1 Protein of Murine
Cytomegalovirus Alters In Vivo Pro-inflammatory TNF-
alpha Production during Acute Infection
Sara Rodrı´guez-Martı´n1., Kai Alexander Kropp1., Vanessa Wilhelmi2, Vanda Juranic Lisnic3, Wei
Yuan Hsieh1, Mathieu Blanc1, Andrew Livingston1, Andreas Busche4, Hille Tekotte5, Martin Messerle4,
Manfred Auer6, Iain Fraser7, Stipan Jonjic3, Ana Angulo8, Matthias J. Reddehase2, Peter Ghazal1*
1Division of Pathway Medicine and Centre for Infectious Diseases, University of Edinburgh, Edinburgh, United Kingdom, 2 Institute for Virology, University Medical Center
of the Johannes Gutenberg University, Mainz, Germany, 3Department of Histology and Embryology/Center for Proteomics, Faculty of Medicine, University of Rijeka,
Rijeka, Croatia, 4Department of Virology, Hannover Medical School, Hannover, Germany, 5Wellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh,
United Kingdom, 6University of Edinburgh, School of Biological Sciences (CSE) and School of Biomedical Sciences (CMVM), Edinburgh, United Kingdom, 7 Laboratory of
Systems Biology, National Institution of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, United States of America, 8 Institut
d’Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain
Abstract
Little is known about the role of viral genes in modulating host cytokine responses. Here we report a new functional role of
the viral encoded IE1 protein of the murine cytomegalovirus in sculpting the inflammatory response in an acute infection. In
time course experiments of infected primary macrophages (MWs) measuring cytokine production levels, genetic ablation of
the immediate-early 1 (ie1) gene results in a significant increase in TNFa production. Intracellular staining for cytokine
production and viral early gene expression shows that TNFa production is highly associated with the productively infected
MW population of cells. The ie1- dependent phenotype of enhanced MW TNFa production occurs at both protein and RNA
levels. Noticeably, we show in a series of in vivo infection experiments that in multiple organs the presence of ie1 potently
inhibits the pro-inflammatory cytokine response. From these experiments, levels of TNFa, and to a lesser extent IFNb, but
not the anti-inflammatory cytokine IL10, are moderated in the presence of ie1. The ie1- mediated inhibition of TNFa
production has a similar quantitative phenotype profile in infection of susceptible (BALB/c) and resistant (C57BL/6) mouse
strains as well as in a severe immuno-ablative model of infection. In vitro experiments with infected macrophages reveal
that deletion of ie1 results in increased sensitivity of viral replication to TNFa inhibition. However, in vivo infection studies
show that genetic ablation of TNFa or TNFRp55 receptor is not sufficient to rescue the restricted replication phenotype of
the ie1 mutant virus. These results provide, for the first time, evidence for a role of IE1 as a regulator of the pro-inflammatory
response and demonstrate a specific pathogen gene capable of moderating the host production of TNFa in vivo.
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Introduction
The b-herpesvirus human cytomegalovirus (HCMV) is a
species-specific virus and a clinically important pathogen that
can establish both acute and latent infections. The murine
counterpart (MCMV) provides a useful model for studying
CMV natural infection in its natural host. CMV has a dsDNA
genome that is sequentially expressed in a hierarchical cascade,
immediate early (IE), early (E) and late (L) [1]. The MCMV IE1
protein has been implicated in the transcriptional activation of
viral early genes in combination with the IE3 protein [2] as well as
in the expression of cellular genes [3–5]. The IE1-induced
activation of gene expression is not completely understood,
although the ability of IE1 to interact with chromatin through
histones [6,7] might be one mode of action responsible for its
transactivating functions.
The ability of MCMV IE1 protein to activate cellular gene
expression has been documented for genes involved in immune
signalling pathways, DNA metabolism and cell cycle control
[3,4,8,9]. Recently, a single point mutation in MCMV IE1 has
been shown to disrupt its capacity of trans-activating cellular genes
ribonucleotide reductase and thymidylate synthase, involved in
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nucleotide metabolism [10]. IE1 is also a potent disruptor of
promyelocytic leukemia gene product (PML) oncogenic domains
(PODs/ND10) [11,12], which have been implicated in intrinsic
cell immunity to infection [13–15]. In vitro, an IE1-deleted MCMV
grows with the same efficiency as wild type MCMV in different
cell types [11]. However, this mutant is severely attenuated in
immune competent BALB/c mice as well as in SCID mice lacking
the adaptive immune control, and shows a reduced doubling time
in various organs of BALB/c mice after hematoablative treatment
[10,11]. On the basis of these studies we have previously
speculated about a putative role of IE1 in interfering with some
early intrinsic or innate immune mechanism [11], involving pro-
inflammatory cytokine production or signalling. In this context,
the homologous HCMV IE1 protein has recently been reported to
counteract the type I interferon response by targeting principally
STAT2 [16]. Moreover, in the case of HCMV, there are an
increasing number of studies pointing to IE1 promoting a nuclear
environment conducive for viral expression by modulating
epigenetic regulation of the viral major immediate early promoter
(MIEP). In these studies, ND10 associated-proteins, in particular
hDaxx, have been shown to be repressors of the MIEP [17]. In this
scenario, the dispersion of ND10s by the IE1 protein at early time
of infection is thought to increase MIEP transcription efficiency
indicating a potential role of ND10s as part of an antiviral defence
mechanism inactivated by IE1 [12]. However, it is important to
note that in the absence of the ie1 gene HCMV, unlike MCMV or
rat CMV [18], displays growth impairment under conditions of
low multiplicity of infection (MOI) on primary fibroblasts [19,20].
The growth phenotype of the HCMV ie1-deficient strains adds an
additional level of complication that can be avoided by utilising a
rodent CMV model. Overall, while the mode of action of IE1 has
been extensively studied in different species of CMV, the
functional relationship of this protein in the regulation of host-
virus interaction pathways, especially in a more biologically
relevant context such as in infection of MW or at a whole
organism level, remains unknown to date.
Macrophages (MWs) play a central role in CMV infection with
regard to viral dissemination, replication and establishment of
latency [21,22]. At the host response level, MWs constitute one of
the principal effectors of innate immunity. Upon activation, MWs
produce a number of pro-inflammatory cytokines such as TNFa,
IL1, IL6, IFNa/b and IL12, which are reported to be key
mediators of the response against MCMV [23–25]. Of these pro-
inflammatory cytokines, TNFa represents a key player in innate
immunity. It is produced in response to a wide range of pathogens
and is a hallmark of inflammatory diseases. One of the main
activities of this pro-inflammatory cytokine is to provide protection
against pathogen invasion. It is therefore not too surprising that
there exist a number of pathogens which have developed several
mechanisms to inhibit or modulate different stages of the TNFa
action, ranging from the blockage of TNFa binding to the receptor
to inhibition of specific TNFa-induced responses, such as gene
expression or caspase activation [26–28]. To date, both human
and mouse CMV have been reported to block TNFa-mediated
gene activation by interfering with cell signalling and TNFa
receptor expression [29–31]. Others have shown that HCMV
inhibits TNFa-induced caspase-dependent apoptosis by encoding
viral inhibitors [32]. It has also been shown that MCMV blocks
caspase-independent apoptosis by direct binding and degradation
of receptor-interacting protein RIP1 by the viral M45 protein
[33,34].
Despite the several known viral strategies to modulate TNFa-
induced responses, there are only a few examples in the literature
of viruses that interfere with TNFa production [35,36]. In
contrast, numerous studies have shown that bacteria and parasites
almost exclusively interfere with TNFa by blocking its production,
specifically targeting p38 MAPK, JNK and NF-kB signalling
pathways involved in the activation of the cytokine production.
For instance, Yersinia outer protein (Yop) J has been reported to
bind to members of the MAPK family and IkB kinase b, and
interfere with the MAPK and NF-kB signal transduction
responsible for activating TNFa production (reviewed in [37]).
In addition, Yersinia pestis was reported to also block TNFa
production in MWs by inhibition of MAPK activation by the
antigenic proteins Low calcium response V (LcrV) and Yop B
[38]. Also in monocytes/MWs, Salmonella SptP protein reduces
TNFa production by blocking the Raf/MAPK signalling pathway
[39] and Escherichia coli K1 protein specifically targets NF-kB for
inhibition of the pro-inflammatory response [40]. Whether any of
the described cell-culture characterised viral or microbial patho-
gen-mediated suppression of TNFa production also occurs in vivo
in an intact physiological system is not known.
We report in vivo and in vitro studies disclosing a previously
unrecognized biological role of MCMV in moderating the
production of pro-inflammatory cytokines, in particular TNFa
involving an IE1 dependent mechanism, detectable at the protein
and transcriptional level, in both immune intact strains of mice
and in a severe immune-ablative model of infection. While the loss
of ie1 results in increased sensitivity of viral replication in
macrophages to TNFa inhibition, in vivo the ablation of TNFa is
insufficient to rescue the replication phenotype.
Results
A comparison of MCMV and MCMVdie1 infection in
primary BMMW
MWs are a key cellular population for MCMV infection.
Furthermore, replication of MCMV in primary bone marrow-
derived macrophages (BMMW) reflects more closely the in vivo
phenotype than the replication in fibroblasts [21]. Accordingly,
our first experiments sought to characterize the level of infection of
MCMVdie1 and parental and revertant MCMV strains in this
Author Summary
The suppression of the production rather than the
blockage of action of the potent inflammatory mediator
TNFa is a particular hallmark of anti-TNFa mechanisms
associated with microbial and parasitic infections. Whether
this mode of counter-regulation is an important feature of
infection by viruses is not clear. Also, it remains to be
determined whether a specific pathogen gene in the
context of an infection in vivo is capable of modulating
levels of TNFa production. In this study we disclose a virus-
mediated moderation of TNFa production, dependent on
the ie1 gene of murine cytomegalovirus (MCMV). The ie1
gene product IE1 is a well-characterized nuclear protein
capable of altering levels of host and viral gene expression
although its biological role in the context of a natural
infection is to date unknown. We provide evidence
showing that ie1 is associated with a moderated pro-
inflammatory cytokine response, in particular with TNFa
production. Further, we show that the viral moderation of
this cytokine is not only readily apparent in vitro but also in
the natural host. The identification of a viral gene
responsible for this mode of regulation in vivo may have
therapeutic potential in the future in both anti-viral and
anti-inflammatory strategies.
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particular cell population. Therefore, bone marrow (BM) cells
were isolated from 10–12 week-old male BALB/c mice for
selection of BMMW during 7 days of maturation in cell culture
before use in infection studies. The F4/80+CD11b+ phenotype of
the BMMW was confirmed by flow cytometry analysis prior to
infection (Figure S1). First, we determined the virion DNA:PFU
ratios for wild-type (referred to as MCMV in this manuscript), ie1
deficient (MCMVdie1) and revertant-virus (MCMVrev) infection
stocks as reported in previous studies [10,41]. Figure 1A shows
that MCMVdie1 develops a similar number of genome equiva-
lents per PFU in comparison with MCMV or MCMVrev.
Furthermore, Western blot analysis determining the level of
expression of the MCMV early protein E1 24-hrs after infection of
BMMW further indicated a similar level of early stage-infection
of MCMVdie1 and control viruses (Figure 1B). For later stages of
infection, the viral growth was determined by standard plaque
assays in a single-hit viral growth analysis in the fibroblast cell line
NIH-3T3 as well as in BMMW (Figure 1C and D, respectively). As
expected the results in Figure 1C show that in fibroblasts
MCMVdie1 had no defective growth in these cells [11]. However,
infection of BMMW (Figure 1D) results in a small but significant
difference in the growth of MCMVdie1 in comparison with
MCMV and MCMVrev. This macrophage phenotype for
MCMVdie1 infection is reflective of its in vivo phenotype [10,11]
and raises the question of whether this might be due to a possible
macrophage-specific pro-inflammatory cytokine response.
Modulation of BMMW cytokine response upon MCMV
and MCMVdie1 infection
On the basis of the attenuated growth phenotype of ie1 null
mutant in infection of mice deficient in adaptive immunity (SCID
mice), we have previously speculated about a role for IE1 in
countering intrinsic or innate cell immunity [11]. As indicated
above, infected macrophages characteristically produce a vigorous
and varied pro-inflammatory cytokine response, in particular
TNFa and are therefore in contrast to other cells, such as NIH
3T3 fibroblast cells that are restricted in their repertoire of
cytokine expression. Since ie1 is known to influence gene
expression, it is plausible that IE1 can affect cytokine gene
expression in monocyte/MW cells. Thus, to directly test the
possibility of IE1 protein modulating the cytokine response in
infected BMMW, we first investigated pro-inflammatory cytokine
production after infection of BMMW. In these experiments, levels
of several cytokines were measured at early times post infection
prior to any new infectious virus production. BMMW were either
mock infected or infected with MCMVdie1 and MCMV at an
MOI of 1. Supernatants were harvested at 10 hpi and flow
cytometry-based Cytometric Bead Array (CBA) was performed for
IFNc, IL10, IL12p70 and TNFa. As seen from Figure 2A none of
the infections differentially altered IFNc, IL10 or IL12p70
production. However, the TNFa production was only mildly
induced by MCMV, but in contrast, MCMVdie1-infected
BMMWs showed a markedly pronounced TNFa response
Figure 1. Comparison of MCMV, MCMVdie1 and MCMVrev. (A) Genome copy number-to-PFU ratios of MCMV, MCMVdie1 and MCMVrev
stocks. Viral DNA was extracted from 200 ml of viral stock from each strain and the number of genome copies per ml was measured by qPCR and
related to infectivity measured as PFU by virus plaque assay. (B) Western blot shows equal infection of BMMW. Total protein was extracted at 24 hpi
and Western blot was carried out to assess the expression of both IE1 and E1 viral proteins, showing that cells were equally infected. (C) (D) Growth of
MCMV, MCMVdie1 and MCMVrev in NIH-3T3 and BMMW cells. Cells were infected with the different viruses at an MOI of 1. At indicated times cellular
supernatant from infected NIH3T3 cells (C) and intracellular and extracellular virus from infected BMMW (D) were harvested and titrated by standard
plaque assays in MEFs. Shown are the median values of 2 independent experiments (n = 3, each experiment) along with SD.
doi:10.1371/journal.ppat.1002901.g001
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producing a .15-fold higher amount when compared to the levels
seen for MCMV-infected cells. It is worth noting that the response
can vary due to batch variability in primary macrophages cultures
and viral stocks. Nevertheless, similar results have been consis-
tently obtained from multiple independent BMMW preparations
using different viral stocks.
Furthermore, after infection of a MW cell line (RAW 264.7 cells)
with MCMVdie1 or another ie1-mutant (IE1stop), an approxi-
mately 15- to 20-fold higher production of TNFa is also observed
in comparison with MCMV (Figure 2B). In the case of the IE1stop
mutant the IE1 open reading frame is selectively interrupted,
without genetically resecting any further sequences, strongly
suggesting that the IE1 protein is responsible for the suppression
of the TNFa production and not any other viral protein, that
might potentially originate from a the MCMV major IE region.
To further characterise the modulation of TNFa by IE1 during
infection we investigated the kinetics of TNFa production. In the
following experiments BMMW were mock-infected or infected
with either MCMVdie1, MCMV or an ie3 defective MCMV
(MCMVdie3) [42] during a 24 h time course. MCMVdie3 is
completely defective for viral replication, with viral gene and
protein expression essentially restricted to the IE1 and IE2
proteins [41] and thus serves as an excellent comparator for the
loss of ie1 in the MCMVdie1 mutant. Figure 2C shows that after
MCMV infection BMMW produced detectable levels of TNFa
from 4 h onward, until 24 h when it started to decrease. In
agreement with the preceding experiment, MCMVdie1 generally
induced higher levels of TNFa. Again, the levels of induction
found in cellular supernatants from MCMVdie1-infected BMMW
were higher than those induced by MCMV. It is noteworthy that
MCMV does not completely inhibit TNFa production and this
may reflect a level of leakiness derived from a pool of low IE1
expressivity of infected cells. Alternatively it could be that low
levels of TNFa may be advantageous. In this time course
experiment MCMVdie3 moderates the TNFa response with
delayed kinetics to the MCMV and MCMVdie1 reaching similar
levels as the MCMV by 24 h post-infection (Figure 2C). The
observation that MCMVdie3 develops lower levels of TNFa than
wild-type MCMV may reflect the importance of an active viral
gene transcription that produces double-stranded viral transcripts
to induce a full TNFa response. This possibility is consistent with
studies showing the role of the cytoplasmic detector for viral RNA
RIG-I in inducing and sustaining a TNFa response to infection
with a DNA-virus [43]. In such a scenario we would anticipate to
see MCMV infection developing higher levels of TNFa than the
MCMVdie3. Thus, while an on-going infection is required to
trigger a full TNFa response these results appear to indicate that
mutation of the ie1 gene is strongly associated with increased
production of the cytokine.
To further evaluate whether the altered production of TNFa
after infection with MCMVdie1 is due to the loss of ie1 gene
function and not an accidental second site mutation in the
recombinant virus, a revertant virus of MCMVdie1 was also
tested. In these experiments BMMW were either mock-infected or
infected with MCMV, MCMVdie1 and MCMVrev. Supernatants
were used to test the levels of TNFa after 10 and 24 hpi. As shown
in Figure 2D significant production of the cytokine was found only
after infection with MCMVdie1 at both time points, whereas
comparably low levels of TNFa were found after infection with
MCMV and MCMVrev.
Figure 2. Cytokine production in infected MWs. (A) Cells were mock-infected or infected with either MCMV or MCMVdie1 (MOI 1). IFNc, IL10,
IL12p70 and TNFa levels from cellular supernatants at 10 hpi were measured by flow cytometry-based CBA. (B) TNFa production after infection of
RAW 264.7 macrophages. Cells were either mock-infected or infected with MCMV, MCMVdie1 or the MCMV IE1stop mutant (MOI 1). TNFa levels from
the supernatants were determined by ELISA at 10 hpi. (C) TNFa production after infection of BMMW with MCMV, MCMVdie1 or MCMVdie3. Cytokine
levels from cellular supernatants were measured by flow cytometry based CBA for 12 h time course, 16 and 24 hpi. (D) TNFa production from mock-
infected BMMW or MCMV-, MCMVdie1- or MCMVrev-infected cells after 10 and 24 h. Cytokine levels were measured by ELISA. Experiments were done
in triplicate and tested in duplicates. Bars show mean values with SE.
doi:10.1371/journal.ppat.1002901.g002
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Overall, the viral deletion mutant experiments indicate that the
MCMV ie1 gene plays a previously undisclosed role in moderating
the production of a key pro-inflammatory cytokine, namely TNFa,
in infected BMMW.
TNFa production is altered in infected cells and not
bystander cells
In our next experiments we sought to determine whether the
production of TNFa is specifically associated with the productively
infected cells, or bystander cells or both. For these studies
immunofluorescence staining monitored the intracellular produc-
tion of TNFa while staining for viral early E1 antigen
simultaneously monitored infection. RAW 264.7 cells were
mock-infected or infected with MCMV or MCMVdie1. After
24 hpi, double labelling was performed for MCMV E1 protein
and TNFa. As shown in Figure 3, production of TNFa was only
detectable in cells that also expressed the E1 protein. LPS was used
as a positive control to trigger TNFa production independent of
viral infection showing that all cells were competent for TNFa
production (Figure S2). These experiments directly show that
induced TNFa production is almost exclusively associated with
infected cells and not by neighbouring bystander cells.
These observations raise the possibility that IE1 might play a
direct role in moderating the TNFa response in infected
macrophages. To explore this possibility and to test whether IE1
alone is capable of moderating TNFa gene expression indepen-
dent of the infection process, we next used transient transfection
assays. To quantify the TNFa promoter activity we constructed a
reporter plasmid, pTNF-gLuc, containing the gaussia luciferase
reporter gene [44,45] under the control of the murine TNFa
promoter/enhancer (position 2670 to +1) element. We first
assessed the activity of the pTNF-gLuc using the cell line Bam25
[42] that stably expresses the viral IE-genes. For these experiments
Bam25 or NIH3T3 cells were transfected with pTNF-gLuc
together with the vector pGL3 (Promega) for normalisation of
the reporter gene expression measurements. As the infection
process results in activation of Toll-like-receptor (TLR) signalling,
triggering the expression of pro-inflammatory cytokines, including
TNFa [46], we sought to ensure TLR activation in the absence of
infection by treating transfected cells with bacterial lipopolysac-
charide (LPS). LPS is a known potent inducer for TNFa gene
expression [47–50]. The transfected cells were incubated for 24 h,
culture medium was changed and subsequently stimulated with
100 ng/ml LPS for 4 h. As a control for inhibition of the LPS
induced TNFa expression, control cultures were pre-treated with
300 nM Trichostatin A (TSA), an established inhibitor of the
TNFa response, for 2 h prior to the LPS stimulation. As shown in
Figure 4A, LPS can further induce the normalised reporter gene
expression in transfected NIH3T3 cells, while the pre-treatment
with TSA inhibits this induction. In contrast to this, LPS
stimulation does not induce higher expression levels of gaussia
luciferase in the Bam25 cell line. These experiments indicate that
the expression of the viral IE-genes results in reduced capacity of
LPS-induced TNFa activation.
Since the Bam25 cells also express IE3 and IE2 proteins in
addition to IE1, we next sought to test if IE1 expression alone is
sufficient to restrict LPS-induced reporter gene expression in MWs.
However, transfection of primary MWs has a low efficiency and
therefore we used RAW G9 cells for these experiments. RAW G9
cells were co-transfected with 125 ng of an IE1-expression
plasmid, or as a negative control the pcR3.1 cloning vector
(Invitrogen), and pGL3 for normalisation. After 48 h incubation
medium was changed and cells stimulated with 10 ng/ml and
100 ng/ml LPS respectively. The results shown in Figure 4B
reveal that transfection with 125 ng IE1 plasmid was sufficient to
block stimulation with both, low and high doses of LPS. These
experiments support the suggestion that IE1 alone is sufficient to
block LPS induced reporter gene expression.
IE1 deficient MCMV infection exhibits increased levels of
tnf gene expression
We next asked whether the absence of IE1 in the context of an
infection of BMMW also has an effect on TNFa expression at the
RNA level. Cells were mock infected or infected at an MOI of 1
with MCMVdie1, MCMV or MCMVrev and harvested for total
RNA extraction after 10 hpi. Total RNA was used in quantitative
(q)RT-PCR to measure relative tnf transcript levels. Data was
normalized against gapdh levels and the levels of tnf from MCMV-
Figure 3. In situ staining of TNFa in viral-infected macrophages. RAW264.7 macrophages were infected with MCMV or MCMVdie1 at an MOI
of 1 for 24 h. Cells were fixed with 4% paraformaldehyde and double staining was performed for TNFa and MCMV E1 protein. DNA was
counterstained with DAPI.
doi:10.1371/journal.ppat.1002901.g003
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infected cells were used as a calibrator. Figure 5 shows relative
levels of tnf transcripts. When compared to the mock-infected
samples, MCMV infection induced expression of tnf RNA
(p,0.05). However, TNFa mRNA levels in the absence of IE1
protein in MCMVdie1-infected BMMW were 2.5-fold higher than
those seen for the parental and revertant MCMVs (p,0.01).
MCMVrev induction of tnf expression was similar to that induced
by MCMV. We conclude from these experiments that the viral-
induced TNFa production is reduced by MCMV in an IE1-
dependent manner in the context of infected MWs.
Investigation of IkBa, JNK and p38 kinase signalling in
the course of infection
TNFa transcription is induced by different stimuli in a cell-type
dependent manner [28,51–54]. The key signalling molecules,
NFkB, JNK and p38 MAPK are a common set of targets by which
microbial and fungal pathogens inhibit TNFa production
[28,37,38,40]. However, in quantitative Western blot experiments
involving infection of BMMWs with MCMV, MCMVdie1 or
MCMVrev analysis of IkBa, p38 and JNK proteins and their
phosphorylated forms (Figure 6A) reveals that at 10 hpi there are
no significant differences between the three different viruses tested
(for quantification see Figure S7). All three viruses induce
activation of both p38 and JNK kinases but not IkBa. The
absence of IE1 upon infection did not result in a differential
change in the level of IkBa or in the expression or phosphorylation
levels of the tested kinases at 10 h post infection. It is possible that
the time point analysed is too late to detect any quantitative
differences and that they may be temporally masked by a range of
cross-talking signalling events during the infection process.
While lack of activation of NFkB by MCMV is consistent with
our previous studies it is possible that its activation is only
detectable at IE times of infection. For the purpose of exploring
whether differences in the activation of NFkB may be observable
at more immediate early times we have used a stably transfected
cell line, RAW G9 cells [55], to visualise the activation of NFkB.
These cells express the NFkB subunit p65 as a GFP fusion protein.
In rested cells the NFkB complex is distributed throughout the
cytoplasm, producing a weak and diffuse GFP signal in the cells
(Figure S4, mock treated sample). After LPS stimulation NFkB is
activated and translocates to the nucleus, leading to an enrichment
of GFP in the nucleus. The translocation of p65-GFP to the
nucleus from the cytoplasm consequently develops a visibly
concentrated nuclear GFP signal. We therefore infected RAW
G9 cells for 45 min and observe enrichment in nuclear fluorescent
cells for LPS but not for MCMV and MCMVdie1 infected
samples (Figure S4). Quantification of the level of cytoplasmic and
nuclear fluorescence indicates similar levels for MCMV and
MCMVdie1. This indicates that MCMV and MCMVdie1 are
equally restrictive for NFkB signalling during the IE1-phase of
infection.
As noted in the previous section the expression of IE1 in the
transient transfection reporter assays appears to have a similar
inhibitory effect on the LPS-induced activity of the TNFa-
promoter as the HDAC inhibitor TSA (Figure 4A). The
mechanism for the TSA-mediated inhibition of TNFa activation
is known to work through inhibiting p38 phosphorylation in RAW
264.7 cells [56]. Therefore we sought to test if IE1 in the transient
transfection assay can interfere with the phosphorylation of p38
after LPS stimulation. RAW cells were either left untreated or
were transfected with pp89UC or pEYFP-C2, an YFP expressing
control vector. 48 h after transfection cells were stimulated with
LPS for 15 min and pp38 levels were analysed by quantitative
western blot analysis (Figure S7). Figure 6B shows, as expected,
that treatment of mock-transfected cells with LPS leads to an
increase in p38 phosphorylation. Notably, transfection with the
Figure 4. IE1 expression can moderate induced TNFa promoter activity. (A) NIH3T3 cells (2IE1) or Bam25 cells (+IE1) were transfected with
50 ng pTNF-gLuc expression plasmid or pcR3.1 as a negative control. For transfection control 50 ng of pGL3 were co-transfected in all cultures. 24 h
post transfection cells were treated for 2 h with 300 nM TSA in PBS or a comparable dilution of DMSO (vehicle) and then LPS (100 ng/ml) stimulated.
GLuc activity was measured and normalised to firefly activity per well. Bars show averages (n = 2) of a representative experiment (Error bars = SE). (B)
RAW cells were transfected with 125 ng of IE1 expression plasmid pp89UC and 50 ng pGL3 for normalisation. 48 h after transfection cells were
stimulated with LPS and normalised gLuc activity was determined. Bars show averages (n = 6) with SE.
doi:10.1371/journal.ppat.1002901.g004
IE1 Moderates the Inflammatory Cytokine Response
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IE1 plasmid (pp89UC) led to a high level of p38 phosphorylation
that could not be further increased by subsequent LPS stimulation.
In our system, the inability of LPS to induce higher levels of pp38
in IE1-expressing cells is not due to an exhaustion of the p38 pool,
since transfection with the YFP control plasmid led to ,1.4-fold
higher signal for pp38 than the transfection with pp89UC (Figure
S7). These experiments therefore indicate that IE1 might impart
the ability to restrict the phosphorylation of p38.
We next sought to extend this observation to the infection
system at IE-times of infection. We compared the induction of p38
phosphorylation by LPS (15 min) in infected RAW cells at 4 and
10 hpi in comparison to mock-infected samples. As shown in
Figure 6B the treatment of control cultures with LPS induces the
phosphorylation of p38. In contrast to this the virus infected
samples showed a slightly weaker signal for pp38 than the mock
infected samples at 4 hpi, indicating that the virus might be
capable to moderate the phosphorylation of p38. MCMVdie1,
however, showed no increased phosphorylation over the MCMV
infection for both the non-stimulated and the LPS stimulated
samples. Normalisation of the pp38 signal to the levels of p38
protein revealed that there was no detectable difference in levels of
pp38 in the LPS stimulated samples (Figure S7). In accordance to
this we found no increase in levels of phosphorylated p38 at
10 hpi. Under these experimental conditions quantification of the
western blot and normalisation to p38 abundance actually
revealed that treatment of MCMVdie1 infected cells induced
slightly less pp38 compared to MCMV infected samples (Figure
S7). To also check for differences in phosphorylation of JNK we
subsequently determined the levels of pJNK on the same
membranes and found that MCMV and MCMVdie1 induced
the same level of pJNK signal as stimulation with LPS (Figure S7).
Altogether these experiments provide evidence against a
mechanism involving IE1 inhibition of p38, NFkB or JNK
signalling for the induction of TNFa in the context of an infected
macrophage.
Role of IE1 in moderating TNFa transcript levels in vivo in
the immune compromised host model of CMV disease
While modulation of TNFa by a wide range of pathogens has
been extensively studied in cell-culture (reviewed in [28]), it
remains to be determined whether such modulation occurs in vivo.
Accordingly, biological significance of cell culture-based observa-
tions should be treated with some caution. Thus, to directly
determine the physiological significance played by IE1 in
moderating TNFa, we next studied the role of MCMV IE1
protein in vivo. As suggested above for BMMWs in cell culture, IE1
modulates TNFa expression already at the transcript level. We
therefore tested if this applies also to TNFa transcription in host
organs relevant to CMV pathogenesis. The experiment was
performed in immune compromised, c-irradiated BALB/c mice,
an established model for lethal, multiple-organ CMV disease [57].
In this model it was demonstrated previously [10] that wild type
MCMV replicates in the liver with a doubling time of ,19 h,
whereas MCMVdie1 was found to be growth-attenuated with a
doubling time extended to ,34 h. Likewise, MCMVdie1 was
found to be growth-attenuated also in spleen and lungs [10]. As
suggested above for BMMWs in cell culture, IE1 modulates TNFa
expression. We therefore tested if this applies also to TNFa in the
liver by quantitating steady-state levels of tnf transcripts with qRT-
PCR. As seen in Figure 7A, TNFa gene expression in both
infected groups is detectable above the baseline defined by
uninfected liver tissue. At first glance, one might conclude that the
TNFa gene expression level is modestly higher in MCMV-infected
livers compared to MCMVdie1. For correctly interpreting the
gene expression data, however, one must consider the different
viral burden in tissue due to the growth-attenuation of the ie1-
deletion mutant [10]. To account for this problem, we normalized
TNFa gene expression to the number of viral E1 transcripts
determined by qRT-PCR (Figure 7B). As shown in Figure 1
expression levels of E1 were comparable in the infected BMMWs
in the in vitro system. However, in the more complex in vivo system
it is unclear at which level this impairment is manifest in the viral
replication cycle. To exclude that an impaired E- or L-gene
expression could influence our normalisation strategy for the qRT-
PCR, we sought to use a method for normalisation that is
independent of transcript levels in infected cells. To normalise for
the different levels of infection in the sampled organs we therefore
directly measured the number of infected cells by in situ
immunostaining for the late major capsid protein (MCP, M86)
(Figure 7C). Regardless of which normalization strategy was used,
the normalised expression level of TNFa was found to be,10-fold
higher in MCMVdie1-infected livers than in MCMV infected
organs. For comparison, normalized gene expression levels of the
cytokines IFNb and IL10 were measured in order to further probe
the role of IE1 in regulating the innate cytokine response.
Interestingly, infection with the ie1-deletion mutant also induced
significantly higher amounts of IFNb transcripts (Figure 7B and C)
as compared to MCMV. In accordance with the IL-10 expression
in BMMWs (Figure 2A), IL10 transcription in the liver was
induced by the infection (Figure 7A) but was not significantly
influenced by IE1 (Figure 7B and C). Altogether, TNFa, and to
some degree also IFNb, are suppressed on the transcript level in an
Figure 5. tnf gene expression in infected-BMMW. Total RNA was
extracted at 10 h after mock infection or MCMV, MCMVdie1 and
MCMVrev infection of BMMW. Quantitative RT-PCR was performed for
relative expression levels of tnf mRNA in these cells. Shown are relative
levels of tnf gene expression, which have been normalized against the
gapdh gene expression and calibrated against MCMV induced-gene
expression. SE bars are also shown (n = 3). Significance of differences in
mRNA levels in MCMV and MCMVrev infected cells compared to mock
infected cells was p,0.05 (*) and for comparison between MCMVdie1
and MCMV or mock p,0.01 (**), respectively (Student’s t-test).
doi:10.1371/journal.ppat.1002901.g005
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ie1-dependent manner in vivo at a relevant organ site of CMV
disease.
MCMV IE1 modulation of TNFa protein levels in vivo
We next determined if transcriptional control by IE1 also
translates into TNFa protein levels in host tissues. In a first set of in
vivo experiments, groups of 4 to 5 BALB/c and C57BL/6 immune
competent mice were infected by the i.p. route, with the viral
mutant and control strains. Viral yields and TNFa levels were
determined at day 4 p.i. for selected organs. As seen in Figure 8 A
and C, MCMVdie1 showed the expected attenuated phenotype in
both mouse strains when compared to MCMV and MCMVrev
[11]. Viral titres in spleen, liver, heart and lung from infected
BALB/c mice were 6-, 12-, 21- and 35-fold reduced, respectively.
The attenuation was even more dramatic in kidneys where the
MCMVdie1 titres were reduced by a factor of .100. In C57BL/
6, as in BALB/c mice, both MCMV and MCMVrev exhibited
comparable replication (Figure 8C). MCMVdie1 titres were
significantly reduced in all organs examined with a 10-fold
reduction in spleen and liver and over 100-fold reduction in
kidneys. From this data we conclude that the attenuation shown by
MCMVdie1 is not mouse strain-dependent, since in BALB/c,
C57BL/6 and also in the 129 strain (data not shown) as well as in
c-irradiated mice [10], the ie1-deletion mutant MCMVdie1 is not
able to replicate as efficiently as MCMV or MCMVrev.
As described above for the RNA expression studies, MCMV
induces TNFa production in an acute infection [58–60], and it is
understood that TNFa levels positively correlate with the level of
infection [59–61]. In agreement with these previous studies we also
observed a positive correlation between TNFa protein levels and
infectivity per gram of tissue in kidneys and heart (Figure S3). On
this basis, TNFa was quantified and cytokine levels were
calibrated against viral titres in those samples where infectious
virus was detectable. Accordingly, normalized TNFa levels are
shown in Figure 8B and D. At day 4 p.i., MCMVdie1 induces by
an order of magnitude higher levels of TNFa than those detected
for MCMVrev in all organs tested except in the spleen of both
BALB/c (C), and C57BL/6 mice, and liver of C57BL/6 mice (D).
Taken together, these results support a role of IE1 in
moderating the production of TNFa in vivo.
Because of the attenuated phenotype of the ie1-deletion mutant,
the virus titres per gram of tissue differ significantly between
infected groups. It is therefore possible that an IE1 expressing virus
is simply able to replicate more efficiently and consequently will
block TNFa production by alternative mechanisms. We therefore
sought to establish an equivalent level of infection (PFU per gram
of tissue) by adjusting the initial infectious dose of the inoculums
and determining TNFa production. In the following experiments,
immune competent BALB/c mice were infected with 36105 PFU
of MCMV or 36106 PFU of MCMVdie1, and both viral titres
and the absolute TNFa response were compared in different
organs at days 4 and 7 post-infection. Under such conditions, viral
titres of MCMV and of the ie1-deletion mutant were found to be
comparable in all organs (Figure 9, left panels), except in the
Figure 6. Investigation of IE1-mediated NF-kB, p38 or JNK activation. BMMWs were mock infected or infected at an MOI of 1 with MCMV,
MCMVdie1 or MCMVrev (n = 3). (A) Western blots for IkBa and the activated forms of the p38 and JNK kinases are shown. (B) Western Blots with
transfected and infected RAW cells after LPS stimulation. RAW cells were transfected with IE1 expression plasmid pp89UC or a control vector (pEYFP-
C2) and stimulated with 10 ng/ml LPS for 15 min or infected (MOI 1) and stimulated at 4 and 10 hpi, respectively.
doi:10.1371/journal.ppat.1002901.g006
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kidneys (Figure 9C) at day 4 p.i. In comparison to day 4 p.i. the
observed reduction in titres by day 7 p.i, is indicative of the
clearance of the virus from these various organs. TNFa levels after
infection were measured in the different organs from viral-infected
and mock-infected mice (right panels). Results show that MCMV
induced TNFa production after 4 days of infection in all organs
tested, except in the heart (Figure 9D). Importantly, there was also
a marked increase in the levels of TNFa between MCMV and
MCMVdie1. In general, the mutant virus induced statistically
higher levels of TNFa in spleen, liver and kidney after 4 days of
infection; however, there was no difference in the heart
(Figure 9D). At one week of infection, viral clearance of both
MCMV and MCMVdie1 has mostly taken place in all organs
tested with the levels of TNFa having returned to mock levels
except for a residual higher level in the spleen for the MCMV
infection (Figure 9A). Strikingly, and in stark contrast to the
MCMV infection, TNFa levels remained elevated in MCMVdie1
infected animals.
Altogether these results show that the production of TNFa can
be significantly moderated by an ie1-dependent mechanism in an
acute in vivo infection by MCMV.
TNFa is sufficient to inhibit MCMVdie1 in vitro but is not
essential for inhibition in vivo
It has been shown by others that despite the protective effects of
TNFa pre-treatment in vitro an in vivo pre-treatment does not
increase survival rates of MCMV infected mice [62]. We therefore
first sought to determine the effect of TNFa on MCMV and
MCVMdie1 replication in macrophages in vitro. Differentiated
macrophage cultures were pre-treated with 1 U/ml or 10 U/ml
recombinant mouse TNFa (Endogen, PIERCE; 10 mg/ml corre-
Figure 7. In situ activation of cellular genes TNFa, IFNb and IL10 during infection of the liver. Immune compromised female BALB/c mice
(n = 3 per group) were infected with 16105 PFU of MCMV or MCMVdie1 or not infected, i.e. uninfected but immune compromised mice to take into
account that a 6.5 Gy total-body c-irradiation by itself slightly stimulates the expression of the genes under investigation. The analysis was performed
10 days after infection. (A) Expression levels (DDCT values) relative to b-actin transcripts. (B, C) Normalisation of the relative expression levels of TNFa,
IFNb, and IL10 to the numbers of E1 transcripts per 500 ng of total RNA (B) or to the numbers of infected MCP+ cells per representative 10-mm2 areas
of liver tissue sections (C) in order to take account of differences in tissue infection density. Throughout, bars represent median values for three mice
per experimental group. Variance bars indicate the range. P values for significance are indicated for group comparisons of interest (unpaired t-test,
two-sided, performed with log-transformed data).
doi:10.1371/journal.ppat.1002901.g007
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sponded to 105 U/ml) for 24 h prior to infection and viral
replication monitored by plaque assay at day 3 p.i. As expected
Figure 10A shows that pre-treatment with TNFa in vitro reduces
viral titres of MCMV. Notably TNFa has a much stronger effect
on the titres of MCMVdie1, which are reduced to the limit of
detection, indicating that MCMVdie1 is more susceptible to
TNFa control compared to MCMV in vitro.
We next sought to determine the contribution of TNFa in
controlling viral replication in vivo by using mouse strains deficient
either in TNFa expression (TNF2/2) or TNFa signalling
(TNFRp552/2). For these investigations groups of mice were
infected with either MCMVdie1 or MCMVrev as indicated in
Figure 10B and viral titres were measured in organs at day 4 p.i. to
investigate if abrogation of TNFa expression or signalling could
enhance or rescue the replication of MCMVdie1. In both tested
mutant mouse strains the impairment of TNFa expression
(TNF2/2) or TNF signalling (TNFR2/2) did not rescue impaired
replication of the MCMVdie1 in the livers, spleens or other organs
analysed (see Figure S5). To complement this experiment and to
control for side effects of the genetic ablation of TNFa we also
analysed the effects of antibody-mediated depletion of TNFa in
vivo. Mice were infected with equal doses of MCMVdie1 and
MCMVrev and anti-TNFa antibodies were injected at day 0 and
2 p.i. As shown in Figure S6 at 4 dpi no significant differences
between the MCMV and MCMVdie1 viruses could be detected in
all analysed organs.
Together these results show that while TNFa is sufficient to
inhibit MCMVdie1 in vitro it is not essential for inhibition in vivo
and may indicate that in the more complex in vivo setting other
host factors can complement for the loss of TNFa function.
Discussion
In this study we have presented evidence revealing that a viral
gene, ie1, of MCMV is involved in altering the pro-inflammatory
cytokine response, in particular TNFa production in vitro and in
vivo. Our results not only identify a new and previously undisclosed
functional role for IE1 in moderating the inflammatory response to
infection, but also show for the first time the association of a
specific pathogen-encoded gene to restrict TNFa protein and
RNA production in vivo in the context of a natural infection.
Several pathogens have been shown to modulate TNFa-
induced response by a wide range of different mechanisms. For
instance, direct interaction with TNFa has been reported for the
M-T2 protein of the Myxoma virus avoiding TNFa-TNFR
interaction [63]. African swine fever virus also targets TNFa-
induced gene expression in infected-MWs by a mechanism
involving the viral protein A238L [64]. Inhibition of TNF receptor
has also been shown for Adenovirus and Poliovirus [65,66].
Moreover, HCMV and MCMV have also been shown to down
modulate TNF receptor expression [29–31], blocking TNFa-
induced gene expression in infected cells. However, there are only
Figure 8. Growth of MCMV, MCMVdie1 and MCMVrev and TNFa production in different organs from infected mice. BALB/c (A, B) or
C57BL/6 mice (C, D) were infected with 36106 PFU or 26106 PFU, respectively, by the i.p. route. Groups of mice (4 to 5 mice per group) were
inoculated with the specified dose of parental MCMV (light grey circles), MCMVdie1 (open circles) or MCMVrev (dark grey circles). On day 4 post
infection mice were killed and the indicated organs were harvested, weighted, and sonicated as a 10% (wt/vol) tissue homogenate in DMEM. (A and
C). Viral titres were determined by standard plaque assay on MEFs. Dashed lines show limit of detection. Dark horizontal marks show median values.
(B and D). Ratios between TNFa levels and PFU in different organs at day 4 after infection are shown in a log scale. Statistically significant differences
in viral titres and TNFa levels between MCMVrev or MCMV and MCMVdie1 are indicated by an asterisk (p,0.05).
doi:10.1371/journal.ppat.1002901.g008
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a few examples in the literature of viral proteins that interfere with
TNFa production [36]. From the literature it can be seen that
targeting the production of TNFa is a common feature in
microbial infections, as seen for Salmonella, Yersinia and E. coli [37–
40]. All known mechanisms by which microbial pathogens alter
the TNFa production involve targeting p38 MAPK and JNK
kinases and/or NF-kB activation (reviewed in [28]). Here, we
demonstrate that the viral IE1 protein of MCMV moderates
TNFa production in infected BMMWs. Moreover, although the
exact mechanism by which IE1 exerts its effect on TNFa
production remains open, our experiments studying the contribu-
tion of key signalling molecules p38 MAPK, and JNK, as well as
NF-kB, suggest that IE1-induced modulation of TNFa production
does not involve altering the function of these signalling proteins.
Although, we do not exclude that the phosphorylation of JNK or
other phosphatases is also influenced by other viral factors and
therefore effects of IE1 deletion on phosphorylation of these
signalling factors could be masked.
Comparison of TNFa levels between MCMV and the
MCMVdie3 mutant virus showed that MCMVdie3 infection
produces much lower levels of TNFa compared to MCMV
infection until 24 hpi. This indicates the importance of viral gene
transcription for inducing and sustaining a full scale TNFa
response. This observation is in good accordance with evidence
showing that RIG-I mediated detection of Myxoma virus
transcripts in human macrophages is necessary to induce a full
TNFa response [45]. Furthermore we show that MCMV does not
completely inhibit TNFa production. It has been demonstrated
Figure 9. Growth of MCMV and MCMVdie1 and TNFa levels in different organs of infected BALB/c mice. Groups of BALB/c mice (4 mice
per group) were inoculated with either 36105 or 36106 PFU of parental MCMV or MCMVdie1, respectively. On day 4 and 7 post infection mice were
killed and spleens, livers, kidneys and hearts (A, B, C and D, respectively) were harvested, weighted, and sonicated as a 10% (wt/vol) tissue
homogenates in DMEM. Left panels. Viral titres were determined by standard plaque assay on MEFs. Grey lines show limit of detection. Black
horizontal marks show median values. Right panels. Levels of TNFa in different organs of infected BALB/c mice. At indicated times organs were
harvested, weighted and homogenated as a 10% (wt/v). TNFa levels were determined by ELISA from the homogenates. Mock infected mice were also
included as a negative control. No significant differences were found in production of infectious virus between infections, except in kidneys at 4 dpi.
Statistically significant differences in TNFa levels are shown as * = p,0.05 or ** = p,0.01.
doi:10.1371/journal.ppat.1002901.g009
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that CMV can reduce the effects of TNFa by down-regulation of
the TNFa receptor during infection [29] and thereby increasing
tolerance to extra-cellular TNFa levels. A major factor determin-
ing permissiveness of cells of the myeloid-monocytic lineage for
infection with CMV is the state of maturation ([67] and references
therein) and it has been demonstrated that TNFa also facilitates
maturation of macrophages [68]. In addition TNFa can be pro-
viral by initiating infection through signalling to the MIE
enhancer. Taken together this indicates that low levels of TNFa
may well be tolerated by CMV and could under certain conditions
also have a pro-viral effect. Thus it may not be to the best
advantage for CMV to completely abrogate TNFa production.
IE1 has been described to have a very general effect on gene
transcription levels including more genes than are controlled by
p38 signalling directly and is better known for its intra-nuclear
activities including the disruption of ND10 bodies [15,69]. In the
case of HCMV, the ability of IE1 to disrupt ND10 bodies has been
correlated with the disruption of an intrinsic defence mechanism
involving nuclear repressor proteins, such as hDaxx and histone
deacetylases (HDACs), to inhibit viral immediate-early gene
expression [17]. In case of MCMV, a direct interaction of IE1
with Daxx and HDAC2 has been demonstrated [12] in good
accordance with the general induction of transcription caused by
IE1 [9], probably involving de-repression of chromatin. It has
been demonstrated that expression of TNFa is partially regulated
by chromatin re-modelling and that treatment with TLR ligands
such as LPS initiates de-repression of chromatin in macrophages
[47,48]. Therefore it is possible that the influence of IE1 on
HDAC function could interfere with TNFa expression by
disrupting the de-repression or maintaining repressive chromatin
associated with the TNFa promoter. It remains to be determined
how IE1 precisely inhibits TNFa expression while also potentially
inducing a de-repression of chromatin.
It is noteworthy that Trichostatin A (TSA), which we used as a
control reagent to block LPS induced TNFa gene expression [56],
is also an inhibitor of HDACs and therefore leads to a general de-
repression of chromatin, while it is capable of inhibiting TNFa
expression [50,56]. This presents parallels between TSA and IE1
and allows speculating that these molecules work potentially
through a similar mechanism. A known mechanism for the effect
of TSA on TNFa is mediated through the p38-inhibtor MAPK
phosphatase-1 (MKP-1). In this case the stability of the interaction
of MKP-1 with its target molecule, p38 MAPK, is regulated by the
acetylation of the interaction site, which is negatively regulated by
HDACs. Treatment with the HDAC inhibitor TSA increases the
level of the acetylated form of MKP-1 and thereby links the
inhibitory function of MKP-1 on the p38 signalling pathway to
HDAC activity [56]. In accordance with this it has been
furthermore demonstrated that LPS stimulation activates
HDAC-3 [50] and is also known to induce expression of HDAC
members in BMMWs [70]. This would negatively regulate MKP-1
activity, increasing p38 signalling and therefore TNFa expression.
Since it is established that IE1 interacts and inhibits HDAC
activity [12] it raises the question if IE1, at least partially, could
function through this mechanism.
In this scenario we would anticipate increased pp38 levels in
MCMVdie1-infected cells. However, we do not detect any
increase in pp38 levels in MCMVdie1 infected cells compared
to MCMV in the first 10 hpi and thus strongly indicating that IE1
does not interfere with p38 phosphorylation in the context of
infection. Although notably, studies have shown that changes in
acetylation of proteins can take up to 9–11 h to occur in the case
of histones [71]. This might indicate that IE1-mediated changes
on MKP-1 acetylation become apparent at later stages of the
infection and could therefore have a role in the late phase of
replication, complementing other viral factors interfering with
Figure 10. TNFa blocks viral replication in vitro but is not essential in vivo. (A) BMMWs were pre-treated for 24 h with TNFa as indicated and
subsequently infected with either MCMV or MCMVdie1 (MOI 1). Total virus was measured by plaque assay at day 3 p.i. and dashed line indicates limit
of detection with bars showing averages (n = 3) with SE. (B) Organs from infected C57B/6, TNFa2/2 or TNFRp552/2 mice (26106 PFU i.p.) were
harvested at 4 d p.i. and homogenated for analysis with standard plaque assay (MCMV = grey circles; MCMVdie1 = open circles). Titres were
normalised per sample weight, black lines indicate median values and dashed line represents limit of detection.
doi:10.1371/journal.ppat.1002901.g010
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TNFa action, such as M45 [29,31]. A more thorough investigation
of MKP-1 and its effects on MCMV replication and induction of
TNFa will be necessary to clarify if IE1 inhibits p38 signalling.
However, it is also noteworthy that the immune-modulatory
cytokine IL10 is induced upon infection by MCMV in MWs and in
vivo and since IL10 is known to function as an anti-inflammatory
mediator, it is possible that a host IL10 autocrine loop might be
involved in modulating TNFa. While we cannot exclude the
possibility for IL10 involvement in TNFa suppression we failed to
detect any significant difference in expression of IL10 between
MCMV with and without ie1 indicating that the mechanism for
TNFa moderation does not involve regulation of IL10.
While many pathogens have been shown to counter-regulate
TNFa production in cell culture, in particular in MWs, little or no
information is available to indicate whether this mode of
regulation also occurs in an in vivo system. Our investigations
show that the viral gene, ie1, in the context of a natural infection
contributes to a significant moderation of TNFa production in
multiple organs in vivo. TNFa levels, relative to the amount of
detected virus, in selected organs were significantly higher in
animals infected with MCMVdie1 than in animals infected with
MCMV or MCMVrev, and this was consistently observed in
several genetic backgrounds and in different infection models. This
is quite striking, as we would anticipate a significantly reduced
inflammatory response to be associated with the severely
attenuated in vivo growth by MCMVdie1. In vivo we observed a
relatively enhanced production of the pro-inflammatory cytokines
TNFa and IFNß but not for the anti-inflammatory cytokine, IL10,
with MCMVdie1 infection. Because of the attenuated phenotype
of the ie1-deletion mutant, the virus titres per gram of tissue differ
significantly between infected groups. It is therefore possible that
an IE1 expressing virus simply is able to replicate more efficiently
in vivo and consequently blocks TNF production through
alternative methods. While we have not investigated in the present
study other similarly attenuated viruses in their ability to develop
an elevated pro-inflammatory cytokine response, we have evalu-
ated TNFa production levels in the context of establishing an
equivalent level of infection per organ between the ie1 deficient
and wild-type strains. These studies clearly indicate that even in
the presence of comparable levels of infection, MCMVdie1
induces significantly higher levels of TNFa. Those levels were
sustained for at least 1 week after infection, whereas wild-type
MCMV-induced TNFa production had returned to the mock-
infected levels by 7 days p.i. The results of our investigation
provide the first demonstration of a counter-regulatory role
encoded by the ie1 gene in moderating the TNFa cytokine
production in the context of a natural infection in vivo. In
accordance with the attenuated in vivo phenotype of MCMVdie1
we could demonstrate a higher sensitivity of MCMVdie1
replication in vitro compared to MCMV but neither genomic
deletion of the TNFa gene, the TNFa receptor gene or in vivo
depletion of TNFa by administration of anti-TNFa antibodies
could rescue the attenuated MCMVdie1 phenotype, indicating
that other anti-viral host factors complement the loss of TNFa
function. In accordance to this we find a slight but significant
increase in IFNb1 expression in infected organs.
In summary, we identify a new biological role for the ie1 gene of
MCMV involving the regulation of pro-inflammatory cytokines,
especially TNFa production, in both in vitro and in vivo infections.
This suggests a novel viral counter-immune strategy preventing a
robust inflammatory response during an infection. Our findings
demonstrate that IE1, in addition to blocking intrinsic cell
defences, also acts as a virulence factor contributing to viral
modulation of the inflammatory response. This new role of ie1
may also have therapeutic anti-viral and anti-inflammatory
applications in the future. In this regard, our results provide the
first evidence of a viral strategy capable of suppressing pro-
inflammatory TNFa production in vivo mediated by a pathogen-
encoded gene.
Materials and Methods
Ethics statement
All procedures involving animals and their care were approved
by the Ethics Committee of the University of Barcelona (Spain)
and were conducted in compliance with institutional guidelines, as
well as with catalan (Generalitat de Catalunya decree 214/1997,
DOGC 2450) laws and policies. In the United Kingdom
experiments were approved by the University of Edinburgh
Animal Procedures and Ethics Committee and were performed
under licence from the United Kingdom Home Office under the
Animals (Scientific Procedures) Act 1986. In Germany, mice were
bred and housed under specified pathogen-free conditions in the
Central Laboratory Animal Facility of the Johannes Gutenberg-
University, Mainz. Animal experiments were approved according
to German federal law under permission number 177-07-04/051-
62. In Croatia all animals were bred and housed at the Breeding
Facility of the Faculty of Medicine, University of Rijeka.
Experiments were approved by the Ethics Committee of the
University of Rijeka and were performed in accordance with the
Croatian Law for Protection of Laboratory Animals (matched with
EU legislation (DIRECTIVE 2010/63/EU OF THE EUROPE-
AN PARLIAMENT AND OF THE COUNCIL of 22 September
2010 on the protection of animals used for scientific purposes).
Cells and viruses
The murine fibroblast cell line NIH3T3 cells (ATCC CRL1658)
and the macrophage cell line RAW 264.7 (ATCC TIB-71) were
obtained from the American Type Culture Collection (Manassas,
VA). Primary murine embryonic fibroblasts (MEFs) were prepared
from embryos of pregnant BALB/c mice on day 16 of gestation.
RAW G9 cell line was constructed as described previously [55] and
expresses a p65-GFP fusion protein under transcriptional control of
the native p65-promoter. NIH3T3, were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% calf
serum (CS) and RAW 264.7, RAW G9 and MEFs were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented 10%
fetal CS (FCS). All cell media also contained 2 mM glutamine and
100 U of penicillin/streptomycin per ml. The ie1-deficient mutant
(MCMVdie1) and corresponding revertant virus were described in
[11]. The IE1stop mutant carries a stop codon at the 59-end of exon
4 of the MCMV ie1 gene preventing the synthesis of the pp89 IE1
protein. Briefly, two successive PCR rounds were performed using
the primer pairs IE1_stop_fw1 (59-GCAATCTTACAGGACAA-
CAGAACGCTCTACACTGGAGGATGACGACGATAAGTA-
GGG-39) and IE1_stop_rv1 (59-TACAAACCACTCTTATATTC-
CAGTGTAGAGCGTTCTGTTGCAACCAATTAACCAATT-
CTGATTAG-39), and IE1_stop_fw2 (59-GATTGATAGTTCT-
GTTTTATCATGAGGTGTGCAATCTTACAGGACAACAG-
AACGCTCTACACTGGA-39) and IE1_stop_rv2 (59-CTGTCT-
TTCATATTCACCCACACAGAACACTTGAGTTATACAAA
CCACTCTTATATTCCAGTGTAGAGCG-39), respectively, to
amplify a kanamycin resistance marker, followed by recombination
in E. coli using the MCMV BAC pSM3fr [72] and applying the en
passant mutagenesis procedure as described in [73] The parental
BAC-derived MCMV strain MW97.01 ([72], named MCMV in
this study) and the recombinant MCMVs were propagated on
NIH3T3 cells. Cells were grown to 70%–80% confluency and
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infected at an MOI of 0.01 with MCMV, MCMVdie1 and
MCMVrev in DMEM supplemented with 2% CS. When cultures
reached cytopathic effect, supernatants were harvested and kept at
270uC after clearing cellular debris. Viral titres were determined by
standard plaque assays on MEFs. Bone marrow derived macro-
phages (BMMW) were prepared from 10–12 week-old male BALB/
c mice as described previously [74]. Femur lavages were plated out
at 56105 or 86105 cells per well (24- and 6-well plates, respectively)
and left for maturation for 7 days in DMEM:F-12 containing 10%
FCS, 10% L929 conditioned media as a source of macrophage
colony stimulating factor [75], and 100 U of penicillin/streptomy-
cin per ml.
Expression plasmids
Plasmid pp89UC codes for the MCMV IE1 protein pp89,
carrying the insert of plasmid pIE 100/1 [2] in the pUC19 vector.
IE1 expression is under control of its native MCMV major
immediate early enhancer/promoter. Plasmid pEYFP-C2 was
produced by transferring the EYFP ORF from pEYFP-C1 (BD
Biosciences Clonetech) into the pEGFP-C2 vector (BD Biosciences
Clonetech), replacing the EGFP ORF using endonucleases AgeI
and BsrGI. The expression plasmid pTNF-gLuc was produced by
replacing the MCMV enhancer/promoter in the plasmid
pmCherryP2AGLucKanR [76] with the TNFa enhancer/pro-
moter (2670 to +1). To do so the TNF enhancer/promoter was
synthesised by MWG/Operon including restriction sites for KpnI
and BglII, used for the cloning procedure.
Lipofection
To transfect cultured cells with expression plasmids we used the
Lipofect LTX reagent (Invitrogen). IE1 or TNF-reporter plasmids
were mixed with the firefly vector pGL3 (Promega) for internal
control of transfection efficiency. To ensure that all cultures were
exposed to the same amounts of DNA during transfection,
mixtures of plasmids were adjusted to the same total amount of
DNA within one experiment with the cloning vector pCR3.1
(Invitrogen). For transfection cell line specific protocols provided
by Invitrogen were used (detailed protocols available at: www.
invitrogen.com/transfections) and adjusted to the respective
culture size as described in the NIH3T3 specific protocol.
Luciferase reporter assays
Gaussia luciferase assays were carried out as described previously
[76], with the exception that plain DMEM medium was used to
produce coelenterazine working solution. Substrate (50 ml) was
mixed with 50 ml culture supernatant and measured with a
POLARstar plate reader (BMG Labtech, UK). To measure firefly
luciferase activity we used the Luciferase Assay System (Promega)
as described in the manual. In short, cells were lysed for 15 min on
a rocking platform and 15 ml lysate were subsequently transferred
into a black/white plate and mixed with 30 ml substrate for
measuring luminescence in the POLARstar plate reader. To
stimulate luciferase expression, cells were washed 16 in growth
medium and then stimulated with LPS (10 or 100 ng/ml in
growth medium, as indicated) for 4 h before reporter gene activity
in the culture supernatant was measured.
Characterization of BMMW by flow cytometry
Maturation of BMMW cells was tested by flow cytometry
analysis for the expression of murine proteins specific for mature
macrophages. Analyses were performed for F4/80 (Caltag
Laboratories, UK) and CD11b (eBiosciences, UK) using a
FACScan or FACSCalibur instrument.
BMMW infection
Cells were infected with the different viruses at an MOI of 1,
unless specified otherwise. After 1 h of adsorption, cells were
washed in PBS and incubated in fresh DMEM:F12 supplemented
with 10% FCS, 10% L929, and 100 U of penicillin/streptomycin
per ml.
Mouse infections
8 weeks-old male BALB/c and C57BL/6 mice were obtained
from Charles Rivers Lab (Barcelona, Spain and Edinburgh, UK,
respectively), C57/Bl6 TNF2/2 mice were obtained from B&K
Universal (UK). Experiments with C57/Bl6 TNFRp552/2 mice
[77] were conducted in the University of Rijeka. Animals were
housed at the animal facilities (University of Barcelona, University
of Rijeka or Edinburgh University) under pathogen-free condi-
tions. Mice were intraperitoneally inoculated with 36105 or 2–
36106 PFU of tissue culture-derived MCMV recombinants. At
designated times mice were sacrificed and spleen, liver, kidneys,
heart and lungs were removed, weighted and harvested as a 10%
(wt/v) homogenate. Part of the tissue homogenate was sonicated
and viral titres were determined on MEF by standard plaque
assay. When infectious virus could not be detected in a particular
organ, a titre corresponding to the limit of detection of the assay
was assigned to that particular organ in order to calculate the
median values.
For in vivo analysis of TNFa transcription levels, female BALB/c
mice were immune depleted and infected essentially as described
in greater detail previously [78]. In brief, hematoablative
conditioning of 8- to 9-week-old female mice was achieved by
total-body c-irradiation with a single dose of 6.5 Gy. Intraplantar
infection at the left hind footpad was performed ,2 h later with
105 PFU of either BAC-cloned virus MCMV wild-type [72] or
MCMVdie1 [11].
TNFa levels
Cytokine levels were determined from cell culture supernatants
by flow cytometry (BD Cytometric Bead Array, BD Biosciences)
and from tissue homogenates by ELISA (mouse TNF-a/
TNFSF1A DuoSet ELISA Development kit, R&D Systems
Europe Ltd.) following manufacturer’s instructions. TNFa con-
centration was determined by reading the absorbance at 450 nm
in a POLARstar OPTIMA Multifunction Microplate Reader
(BMG LabTech, UK).
Immunofluorescence
50 ml of suspension containing 104 cells were added onto each
dot of a Teflon coated microdot slide. Cells were incubated at
37uC for 24 h. After infection and treatment, cells were fixed with
4% paraformaldehyde for 10 min and permeabilized in 0.5%
Triton X-100 for 3 min. After blocking for 1 h with 20% FCS,
cells were stained with primary antibody Croma103 (provided by
S. Jonjic) and TNFa (Santa Cruz, SC-1351) and secondary
antibody Alexa Fluor 488 rabbit anti-mouse IgG and Alexa
FluorAR 594 donkey anti-goat IgG (both from Invitrogen, CA),
respectively.
Nuclear translocation assay
RAW G9 cells (56103 per well) were seeded in glass bottom
optical 384 well plates. After 24 h cells were stimulated with
10 ng/ml LPS or infected with virus in 20 ml. Subsequently cells
were fixed with 4% PFA for 30 min (RT), quenched in 50 mM
NH4Cl solution for 5 min and permeabilised with 0.5% Triton X-
100 for 3 min. Cell nuclei were counterstained with DAPI. For
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analysis pictures were taken on an OPERA system (PerkinElmer,
USA) with 406magnification and for GFP nuclear translocation
assay the corresponding standard script of the Acapella (v2.3)
analysis software was used.
Total RNA extraction from BMMW
RNA from BMMW cells in 6-well plates was extracted by
adding 200 ml Trizol reagent (Invitrogen, CA) and incubating for
5 min. Samples were then transferred to a 1.5 ml microfuge tube
and 40 ml chloroform were added. Samples were incubated at
room temperature for 15 min before being centrifuged
(13,000 rpm, 4uC, 5 min). The upper aqueous layer was removed
and 0.1 volumes 3 M NaOAc, 2.5 volumes EtOH were added.
Samples were incubated (220uC, 60 min) and then centrifuged
(13,000 rpm, 4uC, 30 min). Supernatant was removed and the
pellets washed in 200 ml 70% (v/v) ethanol and centrifuged as
before. RNA pellets were then resuspended in 50 ml RNAse-free
H2O. RNA quantity and quality was assayed by measuring the
A260 and the A260/A280 ratio respectively using a Nanodrop
ND-1000 (Nanodrop Technologies, DE).
Isolation of total RNA from liver tissue
RNA was isolated as described in detail previously [10] from
whole livers shock-frozen in liquid nitrogen.
qRT-PCR
For each sample, 26 Taqman PCR mix (Applied Biosystems;
CA) was mixed with 40 U of Superscript III (Invitrogen, CA). 4 ml
total RNA was then added and each sample split into two
reactions. A Taqman primer/probe set (Applied Biosystems, CA)
for the gene of interest was then added to one reaction at the
recommended concentration while a Taqman primer/probe set
for GAPDH mRNA was added to the other reaction. Samples
were then run on a MX1000P quantitative PCR thermal cycler
(Stratagene, CA). Samples were first heated to 50uC for
30 minutes then heated to 95uC for 10 minutes. Samples were
then subjected to 40 cycles under Taqman standard conditions.
Stratagene MXPro software was used to analyse the data.
Quantification of transcripts
Quantification of b-actin and E1 transcripts was performed with
homemade primers and probes as described previously, yielding
amplicons of 88 bp [10] and 200 bp [79], respectively.
Quantification of IFNb, IL10 and TNFa transcripts was done
with custom-made TaqMan Gene Expression Assays.
(i) IFNb transcripts. TaqMan Gene Expression Assay
(catalog no. Mm00439546-s1; Applied Biosystems). Ampli-
con length: 61 bp.
(ii) IL10 transcripts. TaqMan Gene Expression Assay
(catalog no. Mm00439614-m1; Applied Biosystems). Am-
plicon length: 79 bp.
(iii) TNFa transcripts. TaqMan Gene Expression Assay
(catalog no. Mm00443258-m1; Applied Biosystems). Am-
plicon length: 81 bp.
Reactions were performed in a total volume of 20 ml, including
4 ml of 5 X QIAGEN OneStep RT-PCR buffer, 1 ml of QIAGEN
OneStep RT-PCR enzyme mix, 668 mM of each dNTP, 1.5 mM
additional MgCl2, 0.132 mM 5-carboxy-X-rhodamine as passive
reference, and 0.6 mM of each b-actin primer and 0.26 mM of b-
actin probe, or 1 ml of the corresponding 206 TaqMan Gene
Expression Assay Mix (in the case of IFNb, IL10, and TNFa).
Reverse transcription was performed at 50uC for 30 min. The
cycle protocol for cDNA amplification started with an activation
step at 95uC for 15 min, followed by 40 cycles of denaturation for
15 sec at 95uC and a combined primer annealing/extension step
for 1 min at 60uC during which data collection was performed.
The efficiencies of the RT-PCRs were .90% throughout.
Relative quantifications were made with the comparative CT
(cycle threshold) method as described previously [10,79].
Quantification of viral genomes
Number of viral genomes was determined by measuring copy
numbers of the viral M115 gene as described previously [41].
Quantification of infected cells in liver tissue
Immunohistochemical staining of major capsid protein (MCP;
M86) present within inclusion bodies in the nuclei of infected cells
was performed in liver tissue sections as described previously
[10].
Western blot
Whole lysate was extracted from non-infected and infected-
BMMW using BeadlyteH Cell Signalling Lysis Buffer (Milipore,
UK), following manufacturer’s instructions. BMMWs were cul-
tured for 7 days in 6-well plates at a seeding density of 106 cells/
well. Prior to infection, cells were serum starved for 24 h. After
infection cells were washed with ice-cold TBS and lysed in lysis
buffer, containing Complete Miniprotease Inhibitor (Roche, UK)
and Phosphatase Inhibitor Cocktail I and II (both from Sigma,
UK). Protein concentration was determined using the MicroBCA
protein assay (Pierce, UK), following manufacturer’s instructions.
Equal amounts of protein were mixed with 26 Laemmli Sample
Buffer, containing 10% of DTT and loaded onto a 10% SDS-
PAGE gels. Proteins were transferred to a PVDF membrane
which was then probed with anti-phosphor-p38, anti p38, anti-
phosphor-JNK, anti JNK (Cell Signaling, UK), and anti IkBa
(Sigma, UK) and incubated with HRP-conjugated anti mouse or
rabbit IgG (Cell Signalling, UK). Proteins were detected with ECL
Plus Western Blotting Detection Reagents (Amersham Biosciences,
UK) using VersaDoc imaging system 4000. Densitometric analysis
of the blots was performed by Quantity One software 4.5.0. For
pp38 MAPK and IE1 expression plasmid experiments, RAW
264.7 cells were washed with PBS and resuspended in whole-cell
lysis buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1% NP40,
protease inhibitors, and phosphatase inhibitors), and cell lysates
were centrifuged at 4uC for 10 min and the collected supernatants
were stored at 220uC. Protein concentration was measured by
Pierce BCA assay (Thermo Scientific). For Western blotting,
proteins were separated by 10% SDS-PAGE, transferred to
Immobilon-FL membranes (Millipore), and probed with rabbit
anti-p38a (Santa Cruz, sc-27578, 1:2000), mouse anti-pp38
MAPK (Cell signalling, 9216L, 1:1000), and rabbit anti-b-actin
(Cell Signalling, 4970, 1:2500) diluted in PBST (0.1% Tween20).
For secondary anti-rabbit IR-680 (Invitrogen, A21109, 1:10,000),
IR-800 anti-mouse (Thermo Fisher Scientific, 35571, 1:10,000),
antibodies were diluted in PBST (0.1% Tween20). For visualiza-
tion, the Odyssey protocol (LI-COR) was followed. The fluores-
cence was quantified using ImageJ (ver. 1.45s).
Statistical analysis
Statistical analysis was performed in MATLAB (2007, The
MathWorks, Inc). Viral titres and cytokine levels from in vivo
experiments were compared by using Mann-Whitney U test.
Analysis from in vitro experiments was compared by Student’s t-
test.
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Normalisation procedure
For data normalisation, values of respective control (e.g. firefly
activity) for each sample were expressed relative to the average of
the control in the respective experiment. This normalisation factor
was then used to correct the corresponding measured value in the
assay (e.g. gLuc activity).
Gene accession numbers
(Entrez Gene ID) TNFa (Tnf, 21926), TNFR (Tnfrsf1a, 21937),
p38 (Mapk14, 26416), NFkB-p65 (Rela, 19697), JNK (Mapk8,
26419), Ifnb1 (15977), IL10 (16153), CD11b (Itgam, 16409), F4/
80 (Emr1, 13733), Ifng (15978), MKP-1 (Dusp1, 19252), IL12A
(3592)
Supporting Information
Figure S1 Characterization of BMMW by flow cytome-
try. Maturation of day 7 BMMW assessed by staining for the
specific expression of murine MW cell surface proteins F4/80 and
CD11b. A. FACS dot blot showing the gating forward scatter
(FSC) and side scatter (SSC). (B) This panel shows the population
of F4/80+CD11b+ MW (93.1%). Histograms for F4/80 (C) and
CD11b (D) staining are also shown.
(TIF)
Figure S2 Positive activation of MW after LPS stimula-
tion. As a control for normal activation of cells, RAW264.7
macrophages were stimulated with LPS for 6 h. Cells were then
fixed with 4% paraformaldehyde and staining was performed for
TNFa. Cytokine production was compared to mocked-stimulated
cells. DNA was counterstained with DAPI.
(TIF)
Figure S3 Correlation between TNFa levels and infec-
tious virus in heart and kidney after 4 days of MCMVrev
infection. Pearson’s correlation coefficient shows a significant
correlation between the levels of cytokine produced and PFU per
gram of tissue in kidneys (A) and heart (B) from MCMVrev-
infected BALB/c mice for 4 days.
(TIFF)
Figure S4 Infection with MCMV and MCMVdie1 sup-
presses NFkB activation and translocation to the
nucleus. (A) RAW G9 cells, stably expressing a NFkB(p65)-
GFP fusion protein, were infected or LPS treated and 45 min after
the first contact with virions cells were fixed in 4% PFA,
counterstained with DAPI and GFP translocation was monitored
with an OPERA system (PerkinElmer). (B) Quantification of
cytoplasmic and nuclear GFP fluorescence in treated cells.
OPERA Acapella analysis software was used to quantify
fluorescence in treated cells in 3 different snapshots of 4 wells
per respective treatment. A standard fluorescence translocation
script from the Acapella software (‘‘NFkB Cytoplasm to Nuclei
Translocation Assay’’) with standard settings was used for
quantification of nuclear NFkB translocation. Bars represent
averages of normalised fluorescence with SE.
(TIF)
Figure S5 Viral replication in organs of TNF2/2 and
TNFR2/2 mice. Organs from infected C57B/6, TNFa2/2 (A)
or Balb/c TNFRp552/2 (B) mice (26106 PFU i.p.) were
harvested at 4 dpi and homogenated for analysis with standard
plaque assay (MCMV=grey circles; MCMVdie1= open circles).
Titres were normalised per sample weight, black lines indicate
median values and dashed line represents limit of detection.
(TIFF)
Figure S6 Viral replication in organs of Bl6 mice treated
with 100 ug of anti-TNFa antibody (IP) at day 0 and day 2
p.i. Organs from infected mice (36105 PFU i.p.) were harvested
at 4 dpi and homogenated for analysis with standard plaque assay.
Black lines indicate median values and dashed line represents limit
of detection.
(TIF)
Figure S7 Quantification of LiCor western blot images
for detection of p38/pp38 and pJNK. Average of quantifi-
cation (n = 3) of one representative experiment is shown, error bars
represent SE of quantification. MCMVdie1 is abbreviated as die1
in this figure. (A) Quantification of pp38/p38 levels and
normalised signal intensity in plasmid transfected RAW cells after
LPS stimulation. (B) Quantification of pp38/p38 and pJNK levels
and normalised signal intensity in infected RAW cells at 10 hpi
after LPS stimulation. (C) Quantification of pp38/p38 levels and
normalised signal intensity infected RAW cells at 4 hpi after LPS
stimulation. (D) Densitometric quantification of IkBa, pp38 and
pJNK levels at 10 hpi.
(TIF)
Figure S8 Characterisation of fluorochrome conjugated
primary anti-TNF antibody by flow cytometric analysis.
BMMWs were stimulated with indicated concentration of LPS and
stained with anti-TNF antibody or isotype control antibody.
Fluorescence was analysed using a FACScan instrument.
(TIF)
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